Sangamo Therapeutics (NASDAQ:SGMO) Earns Sell Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on the company. Royal Bank of Canada reaffirmed a sector perform rating and set a $2.00 price […]

Related Keywords

Canada ,United States , ,Miracle Mile Advisors ,Sangamo Therapeutics Company Profile ,Royal Bank ,Sangamo Therapeutics Inc ,Mackenzie Financial Corp ,Vanguard Personalized Indexing Management ,Mirae Asset Global Investments Co ,Sangamo Therapeutics ,Free Report ,Get Free Report ,State Equity Partners ,Financial Corp ,Mile Advisors ,Personalized Indexing Management ,Mirae Asset Global Investments ,Asset Global Investments ,Sangamo Therapeutics Daily ,